chr6-64912625-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM1BP4_StrongBP6_Very_Strong
The NM_001142800.2(EYS):c.2500G>A(p.Val834Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000422 in 1,551,080 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V834L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001142800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.2500G>A | p.Val834Ile | missense_variant | 16/43 | ENST00000503581.6 | |
EYS | NM_001292009.2 | c.2500G>A | p.Val834Ile | missense_variant | 16/44 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.2500G>A | p.Val834Ile | missense_variant | 16/43 | 5 | NM_001142800.2 | A2 | |
EYS | ENST00000370621.7 | c.2500G>A | p.Val834Ile | missense_variant | 16/44 | 1 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00230 AC: 350AN: 152036Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000519 AC: 81AN: 155948Hom.: 0 AF XY: 0.000484 AC XY: 40AN XY: 82588
GnomAD4 exome AF: 0.000217 AC: 304AN: 1398926Hom.: 1 Cov.: 33 AF XY: 0.000207 AC XY: 143AN XY: 689930
GnomAD4 genome AF: 0.00231 AC: 351AN: 152154Hom.: 1 Cov.: 32 AF XY: 0.00230 AC XY: 171AN XY: 74404
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | EYS: BP4 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 30, 2021 | See Variant Classification Assertion Criteria. - |
Retinitis pigmentosa 25 Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jun 15, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 20, 2014 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at